Abstract: A power take-off shaft system for an agricultural vehicle includes an output shaft with a socket for a power take-off shaft stub located at one end of the output shaft, wherein the power take-off shaft stub is arranged in the socket. A control valve is arranged in the output shaft and includes a valve bore extending axially from the socket into the output shaft. A first piston is adjustably arranged inside the valve bore in the output shaft, and a shifting element is adjustably controlled by the first piston. A first gearwheel and a second gearwheel are disposed in engagement with the output shaft via the shifting element such that the first piston is adjustable between a first position and a second position. The control valve includes a second piston arranged on the first piston, where the first piston is adjustable into a neutral position by the second piston.

Abstract: The present disclosure provides methods for the treatment of irritable bowel syndrome (IBS) and/or functional dyspepsia. In particular, the present disclosure provides methods for the treatment of irritable bowel syndrome (IBS) and/or functional dyspepsia through administration of antibodies that bind to human Siglec-8 or compositions comprising said antibodies. The present disclosure also provides articles of manufacture or kits comprising antibodies that bind to human Siglec-8 for the treatment of irritable bowel syndrome (IBS) and/or functional dyspepsia.

Abstract: A power take-off shaft system includes an output shaft with a socket for a power take-off shaft stub located at one end of the output shaft. A control valve is arranged in the output shaft and includes a valve bore extending axially from the socket into the output shaft. A first piston is adjustably arranged inside the valve bore in the output shaft, and a shifting element is adjustably controlled by the first piston. A first gearwheel and a second gearwheel are disposed in engagement with the output shaft via the shifting element such that the first piston moves between a first position and a second position. The control valve includes a second piston arranged on the first piston, and the second piston is adjustable such that movement of the first piston into the second position is blocked by the second piston.

Abstract: The present disclosure provides methods and kits suitable for administering a composition comprising an antibody that binds to human Siglec-8, e.g., to a human individual in need thereof. In some embodiments, a corticosteroid is administered to the individual at least 6 hours, at least 12 hours, or 12-24 hours prior to the first dose of the composition comprising the anti-Siglec-8 antibody.

Abstract: The present invention involves novel urea compositions for oral administration, that are useful for treatment or management of hyponatremia. Also disclosed are novel methods of making the urea compositions.

Abstract: A data handling device includes a plurality of data storage units that are adapted for long term redundant storage of data, generate heat during operation, and are mounted in a manner allowing cooling, and data accessing circuitry adapted determine information chunks relating to data to be stored such that a subset of the information chunks suffice for reproduction of the data, select several of the plurality of data storage units, write the information chunks onto the selected data storage units, determine from which of the selected data storage units to retrieve information chunks based on temperatures of the data storage units to reproduce the data, where at least some of the subset of data storage units are mounted to be cooled by a common vertical air.

Abstract: The present disclosure provides methods for the treatment of mast cell gastritis, mast cell esophagitis, mast cell colitis, mast cell enteritis, mast cell duodenitis, and/or mast cell gastroenteritis. In particular, the present disclosure provides methods for the treatment of mast cell gastritis, mast cell esophagitis, mast cell colitis, mast cell enteritis, mast cell duodenitis, and/or mast cell gastroenteritis through administration of antibodies that bind to human Siglec-8 or compositions comprising said antibodies. The present disclosure also provides articles of manufacture or kits comprising antibodies that bind to human Siglec-8 for the treatment of mast cell gastritis, mast cell esophagitis, mast cell colitis, mast cell enteritis, mast cell duodenitis, and/or mast cell gastroenteritis.

Abstract: The present invention involves novel urea compositions for oral administration, that are useful for treatment or management of hyponatremia. Also disclosed are novel methods of making the urea compositions.

Abstract: In some embodiments, a system for providing DisplayPort communication over an extension medium is provided. The system comprises an upstream facing port device (UFP device) and a downstream facing port device (DFP device). The UFP device is configured to conduct link training with a DisplayPort source device using first DisplayPort configuration data (DPCD). The DFP device is configured to conduct link training with the DisplayPort sink device using second DPCD different from the first DPCD. The UFP device is configured to extract video data from DisplayPort data received from the DisplayPort source device and transmit the video data to the DFP device. The DFP device is configured to receive the video data, generate DisplayPort data as specified by the second DPCD, and transmit the generated DisplayPort data to the DisplayPort sink device as specified by the second DPCD.

Abstract: A method and a device for creating and training machine learning models is disclosed. In an embodiment, a method for training a machine learning model for identifying entities from data includes creating a first plurality of clusters from a first plurality of data samples in a first dataset and a second plurality of clusters from a second plurality of data samples in a second dataset. The method further includes determining a rank for each of the first plurality of clusters and a rank for each of the second plurality of clusters. The method includes retraining the machine learning model using at least one of the first plurality of clusters weighted based on the rank determined for each of the first plurality of clusters and at least one of the second plurality of clusters weighted based on the rank determined for each of the second plurality of clusters.

Abstract: A computer-implemented method and apparatus for facilitating a provisioning of advertisements to customers effects display of one or more advertisements on a Web domain. Each displayed advertisement is configured to offer advertisement related assistance to customers visiting the Web domain. A selection input provided by a customer on an advertisement is received. In response to the receipt of the selection input, the system facilitates customer engagement with a customer support representative associated with an enterprise related to the advertisement. The customer engagement facilitated through the advertisement is configured to provide the advertisement related assistance to the customer.

Abstract: The present invention involves a novel method for treatment of coronavirus infection, including SARS-COV-2. The method comprises administering stannous protoporphyrin and/or cyanocobalamin to a human patient at risk for developing complications from coronavirus infection. The method is particularly useful where a patient has been diagnosed with coronavirus infection or has been exposed to coronavirus but has not developed symptoms of coronavirus infection.

Abstract: The present invention involves a novel method for treatment of chronic kidney disease comprising administering a compound that induces a stress protein response in a patient, and administering a potent antioxidant if the patent's response is below a predefined level. It also involves a quantitative measure for determining a patient's antioxidant reserve capacity.

Abstract: The present invention relates to novel tetrahydrocurcumin (THCu) compositions, novel methods of manufacturing, and methods of using these compositions for therapeutic applications. The novel synthetic pathway(s) result in THCu compositions that generally lack hexahydrocurcumin (HHC), and include an improved impurity profile with reduced additional species that are generally present in hydrogenated curcumin compositions.

Abstract: Extension devices such as upstream facing port devices (UFP devices) and downstream facing port devices (DFP devices) connect via an extension medium. When a UFP device and a DFP device pair with each other, DisplayPort video and/or audio information from a DisplayPort source device can be presented by a DisplayPort sink device, which are coupled to the UFP device and DFP device, respectively. In some embodiments, the DFP device may train a DisplayPort link to the DisplayPort sink device regardless of whether it is receiving actual data from a UFP device, and may provide placeholder data to the DisplayPort sink device in order to keep the link active. The DFP device may then replace the placeholder data with the actual data from the UFP device, once received, and may thereby seamlessly switch the DisplayPort sink device from presenting placeholder data to presenting data from the DisplayPort source device.

Abstract: The present invention involves novel urea compositions for oral administration, that are useful for treatment or management of hyponatremia. Also disclosed are novel methods of making the urea compositions.

Abstract: An extractive system, such as SPME, has an adsorptive phase in the form of a porous coating that has essentially vertical, mutually supporting, columnar structures with nanospaces at the boundaries of the grains.

Abstract: Systems and methods of improving the operation of a transaction network and transaction network devices is disclosed. A transaction network host may comprise various modules and engines as discussed herein wherein the probability that a transaction is a business or personal transaction may be evaluated for establishing proper usage of differentiated transaction instruments according to their proper purposes. For instance, a probable personal transaction may be identified as being associated with a business-oriented transaction card, whereby the transaction network may tailor the handling of the transaction, such as by denying it, whereby the transaction network may actively deter misuse of transaction products whereby the transaction network more properly functions according to approved parameters.

Abstract: A method for reserving access to a shared space through use of a blockchain and smart contracts includes: storing a blockchain including a plurality of blocks, each block including a block header and one or more blockchain data values, wherein one of the one or more blockchain data values included in one of the plurality of blocks includes a smart contract including at least an identifier and one or more terms; receiving a reservation request, wherein the reservation request includes at least the identifier, a reservation time, a public key of a cryptographic key pair, and a digital signature generated using the private key of the cryptographic key pair; validating the digital signature using the public key; executing the smart contract using the public key and the reservation time; and transmitting one or more data values to an internet-enabled device as part of the execution of the smart contract.

Abstract: Pharmaceutical formulations of tetrahydrocurcumin and liposomes are described herein. The liposomes may comprise at least a first lipid, wherein the first lipid is a phospholipid or polyenylphosphatidylocholine are also disclosed.